These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8992875)

  • 21. Intermittent and continuous administration of the bisphosphonate ibandronate in ovariohysterectomized beagle dogs: effects on bone morphometry and mineral properties.
    Monier-Faugere MC; Geng Z; Paschalis EP; Qi Q; Arnala I; Bauss F; Boskey AL; Malluche HH
    J Bone Miner Res; 1999 Oct; 14(10):1768-78. PubMed ID: 10491225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of the effects of genistein, estradiol and raloxifene on the murine skeletal system.
    Sliwiński L; Folwarczna J; Nowińska B; Cegieła U; Pytlik M; Kaczmarczyk-Sedlak I; Trzeciak H; Trzeciak HI
    Acta Biochim Pol; 2009; 56(2):261-70. PubMed ID: 19401787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1,25-dihydroxyvitamin D3 corrects bone loss but suppresses bone remodeling in ovariohysterectomized beagle dogs.
    Malluche HH; Faugere MC; Friedler RM; Fanti P
    Endocrinology; 1988 May; 122(5):1998-2006. PubMed ID: 3359973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of calcitriol in the management of osteoporosis.
    Malluche HH; Faugere MC
    Metabolism; 1990 Apr; 39(4 Suppl 1):24-6. PubMed ID: 2325567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteoblastic insufficiency is responsible for maintenance of osteopenia after loss of ovarian function in experimental beagle dogs.
    Malluche HH; Faugere MC; Rush M; Friedler R
    Endocrinology; 1986 Dec; 119(6):2649-54. PubMed ID: 3780545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone changes occurring early after cessation of ovarian function in beagle dogs: a histomorphometric study employing sequential biopsies.
    Faugere MC; Friedler RM; Fanti P; Malluche HH
    J Bone Miner Res; 1990 Mar; 5(3):263-72. PubMed ID: 2333786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of coumarin-dihydropyridine hybrids as bone anabolic agents.
    Sashidhara KV; Kumar M; Khedgikar V; Kushwaha P; Modukuri RK; Kumar A; Gautam J; Singh D; Sridhar B; Trivedi R
    J Med Chem; 2013 Jan; 56(1):109-22. PubMed ID: 23214410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of salmon calcitonin on experimental osteoporosis induced by ovariectomy and low-calcium diet in the rat.
    Mochizuki K; Inoue T
    J Bone Miner Metab; 2000; 18(4):194-207. PubMed ID: 10874598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of orchidectomy on bone metabolism in beagle dogs.
    Fukuda S; Iida H
    J Vet Med Sci; 2000 Jan; 62(1):69-73. PubMed ID: 10676893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoblast numbers after calcitonin therapy: a retrospective study of paired biopsies obtained during long-term calcitonin therapy in postmenopausal osteoporosis.
    Gruber HE; Grigsby J; Chesnut Ill CH
    Calcif Tissue Int; 2000 Jan; 66(1):29-34. PubMed ID: 10602841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salmon calcitonin prevents cyclosporin-A-induced high turnover bone loss.
    Stein B; Takizawa M; Katz I; Joffe I; Berlin J; Fallon M; Epstein S
    Endocrinology; 1991 Jul; 129(1):92-8. PubMed ID: 2055207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of changes in histomorphometric, bone mass, and biochemical parameters in ovariohysterectomized dogs.
    Shen V; Dempster DW; Birchman R; Mellish RW; Church E; Kohn D; Lindsay R
    Bone; 1992; 13(4):311-6. PubMed ID: 1389570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of calcitonin on bone quality and osteoblastic function.
    Wallach S; Farley JR; Baylink DJ; Brenner-Gati L
    Calcif Tissue Int; 1993 May; 52(5):335-9. PubMed ID: 8504368
    [No Abstract]   [Full Text] [Related]  

  • 34. Growth hormone, osteoblasts, and marrow adipocytes: a case report.
    Kröger H; Soppi E; Loveridge N
    Calcif Tissue Int; 1997 Jul; 61(1):33-5. PubMed ID: 9192509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of etidronate-mediated suppression of bone remodeling on aluminum-induced de novo bone formation.
    Quarles LD; Drezner MK
    Endocrinology; 1992 Jul; 131(1):122-6. PubMed ID: 1611990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of calcitonin administration on young pig trabecular bone remodeling.
    de Vernejoul MC; Pointillart A; Bourdeau A; Morieux C; Modrowski D; Miravet L; Caulin F
    Bone; 1990; 11(1):29-33. PubMed ID: 2331428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovariectomy and trabecular bone remodeling in the dog.
    Dannucci GA; Martin RB; Patterson-Buckendahl P
    Calcif Tissue Int; 1987 Apr; 40(4):194-9. PubMed ID: 3107772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Postmenopausal bone loss. Role of estrogens].
    Trémollières F; Pouilles JM; Ribot C
    Presse Med; 1992 May; 21(19):903-6. PubMed ID: 1386433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. History of calcitonin.
    Chesnut CH
    Lancet; 2002 Sep; 360(9335):801. PubMed ID: 12241848
    [No Abstract]   [Full Text] [Related]  

  • 40. [The effect of long-term calcitonin administration on bone cells and bone mineralization in the rat (author's transl)].
    Schulz A; Delling G
    Virchows Arch A Pathol Anat Histol; 1976 Feb; 369(3):229-38. PubMed ID: 816060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.